General Dermatology

Discover how a proprietary extract from saw palmetto promotes hair growth and reduces thinning in adults, offering a safe alternative to traditional treatments.

The study provides new evidence beyond previously established associations with breast, ovarian, and uterine cancers.

This review of the latest dermatologic studies includes a new instrument to measure QoL in pediatric alopecia, BTX-A in patients with recessive dystrophic epidermolysis bullosa, eosinophilic pustular folliculitis in children, and more.

Citius Oncology’s IL-2 receptor–directed fusion protein offers rapid responses and pruritus improvement for relapsed or refractory stage I–III CTCL.

Support vital dermatology organizations this Giving Tuesday and beyond to enhance patient care, drive research, and foster community.

Patrick Burnett, MD, PhD, of Arcutis, explores new treatments for vitiligo and hidradenitis suppurativa, while advancing systemic biologics for atopic dermatitis by 2026.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about LNK01004's phase 2 AD results, INF904's efficacy in HS and CSU, new data supporting tralokinumab for hand AD, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Explore the top headlines of the month, including insights on regulatory updates, expert pearls, and more.

Dermatology Times is looking back on the top stories in dermatology from the month of November.

Hair growth, density, and aging patterns differ across populations, influencing the presentation and management of hair disorders like alopecia areata.

Learn more about the in-depth topics covered in the November 2025 print issue of Dermatology Times.

Dermatology Times is recapping our exclusive expert interviews from the month of November.

This review of the latest dermatologic studies highlights new research from this week, including immune checkpoint inhibitors in acral melanoma, the link between skin microbiota and asthma, a novel peptide–hyaluronic acid lip serum, and more.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.

In case you missed it, this week we had news about the phase 2/3 research on VDPHL01, new data on the DecisionDx-Melanoma GEP test, roflumilast's sNDA for pediatric plaque psoriasis, and more.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Explore the latest advancements and expert insights from ISDS 2025 held in New York, New York.

Dupilumab clears AD clinically and histologically, but deep immune profiling shows disease-memory T cells persist in the skin.

Stacey Swinehart, DNP, FNP-BC, DCNP, CNL, shares key takeaways for clinicians from the SDNP's recent webinar on detecting intimate partner violence among patients.

Benjamin Ungar, MD, shares groundbreaking insights on seborrheic dermatitis and emerging treatments in dermatology at ISDS 2025.

A recent survey reveals patients prioritize board-certified dermatologists and increasingly favor teledermatology for faster, accessible care.

Explore how skin aging and cellular senescence impact overall health, revealing insights into anti-aging strategies and cosmetic conundrums.

Kilian Eyerich, MD, PhD, argues that classifying skin diseases by immune response patterns offers clearer therapeutic guidance than traditional morphology.